Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Avalon GloboCare Corp. (ALBT : NSDQ)

• Company Description    Avalon GloboCare Corp. is a clinical-stage biotechnology company. It involved in developing and delivering innovative, transformative cellular therapeutics, precision diagnostics and clinical laboratory services. Avalon GloboCare Corp. is based in FREEHOLD, N.J. Number of Employees: 5

• Price / Volume Information    Yesterday's Closing Price: $2.78 Daily Weekly Monthly 20 Day Moving Average: 86,763 shares Shares Outstanding: 1.89 (millions) Market Capitalization: $5.27 (millions) Beta: 0.03 52 Week High: $11.66 52 Week Low: $2.11 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -24.46% -27.66% 12 Week -28.72% -41.41% Year To Date -14.72% -18.75%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 4400 ROUTE 9 SOUTH SUITE 3100 - FREEHOLD,NJ 07728 USA ph: 732-780-4400 fax: 732-780-5600 avco@crescendo-ir.com http://www.avalon-globocare.com

• General Corporate Information    Officers David K. Jin - Chief Executive Officer; President and Director Wenzhao Lu - Chairman Luisa Ingargiola - Chief Financial Officer Steven A. Sanders - Director Lourdes Felix - Director Peer Information Avalon GloboCare Corp. (CORR.) Avalon GloboCare Corp. (RSPI) Avalon GloboCare Corp. (CGXP) Avalon GloboCare Corp. (BGEN) Avalon GloboCare Corp. (GTBP) Avalon GloboCare Corp. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 05344R302 SIC: 7371 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/18/25 Share - Related Items Shares Outstanding: 1.89 Most Recent Split Date: 10.00 (0.07:1) Beta: 0.03 Market Capitalization: $5.27 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/18/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 3.85 EPS Growth vs. Year Ago Period: 20.52% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 11.11% vs. Previous Quarter: 1.45% ROE 03/31/25 - - 12/31/24 - - 09/30/24 - - ROA 03/31/25 - -50.13 12/31/24 - -39.33 09/30/24 - -73.69 Current Ratio 03/31/25 - 0.19 12/31/24 - 0.23 09/30/24 - 0.11 Quick Ratio 03/31/25 - 0.19 12/31/24 - 0.23 09/30/24 - 0.11 Operating Margin 03/31/25 - -647.29 12/31/24 - -592.87 09/30/24 - -1,125.59 Net Margin 03/31/25 - -647.29 12/31/24 - -592.87 09/30/24 - -1,125.59 Pre-Tax Margin 03/31/25 - -659.14 12/31/24 - -592.87 09/30/24 - -1,125.59 Book Value 03/31/25 - -9.83 12/31/24 - -11.37 09/30/24 - -13.69 Inventory Turnover 03/31/25 - - 12/31/24 - - 09/30/24 - - Debt-to-Equity 03/31/25 - - 12/31/24 - - 09/30/24 - - Debt-to-Capital 03/31/25 - - 12/31/24 - 0.00 09/30/24 - 25.17

Powered by Zacks Investment Research ©